LataMed AI Corp. (OTC: LMED), a healthcare technology company focused on digital health and artificial intelligence solutions for Latin America, has announced a new agreement with the Venezuelan Institute for Scientific Research (IVIC) to develop a digital platform module. This module aims to facilitate access to designated laboratory and scientific services, marking a strategic expansion of the company's capabilities beyond patient-facing telemedicine.
Under the agreement, LataMed AI, through its Venezuelan operating subsidiary LATAMEDAI VE, will collaborate with IVIC on the design, development, testing, and implementation of a digital interface. This interface is intended to allow authorized business and institutional users to request available laboratory services, schedule appointments, monitor the status of submitted requests, access approved reports and documentation, and complete authorized payment-related processes. The proposed module seeks to provide a centralized digital workflow for organizations in sectors such as healthcare, pharmaceuticals, food production, agriculture, and related industries.
The specific services to be made available through the platform will be determined by IVIC and implemented in accordance with technical, operational, security, and legal requirements established by both parties. The initial phase will involve defining functional requirements, user-access procedures, data architecture, payment workflows, document-management capabilities, and a phased testing and implementation process. The parties will also establish procedures for handling, transmitting, storing, and accessing laboratory-related information securely.
Potential platform functionalities include electronic service requests, appointment scheduling, request-status tracking, secure payment facilitation, and controlled access to laboratory reports or other authorized documentation. However, the final functionality, implementation schedule, and scope of services remain subject to continued development, testing, and approval.
Dr. Kevin Rodan Levy, Chief Executive Officer of LataMed AI, commented, “This agreement represents an opportunity to apply our technology to an important area of scientific and enterprise service delivery. Our objective is to work with IVIC to develop a responsible digital framework that makes it easier for authorized users to request services, manage appointments, monitor processes, and access approved information through a centralized platform.”
Management believes this initiative could expand LataMed AI's capabilities by demonstrating how its technology can support institutional and enterprise workflows involving healthcare, scientific services, laboratory coordination, and digital documentation. It aligns with the company's broader strategy of developing digital infrastructure that connects patients, healthcare professionals, pharmacies, insurers, payment providers, wellness organizations, and institutions across the healthcare and scientific-services ecosystem.
If successfully implemented, the module could potentially be adapted for other institutional and enterprise service environments in Venezuela and elsewhere in Latin America. However, any future expansion would be subject to separate agreements, technical readiness, regulatory requirements, and the needs of participating institutions.
The agreement establishes the framework for collaboration but does not guarantee a specific implementation date, user adoption level, service volume, revenue, profitability, or expansion to additional institutions. The company will provide updates as development progresses.
For more information, visit https://latamed.ai or review the company's filings with the U.S. Securities and Exchange Commission at www.sec.gov.
